IL-1β+ macrophages and the control of pathogenic inflammation in cancer

Nicoletta Caronni(The San Raffaele Telethon Institute for Gene Therapy), Federica La Terza(The San Raffaele Telethon Institute for Gene Therapy), Luca Frosio(Vita-Salute San Raffaele University), Renato Ostuni(Vita-Salute San Raffaele University)
Trends in Immunology
April 2, 2025
10.1016/j.it.2025.03.001
Cited by 23

Abstract

Related Papers

The Interleukin-1 Family: Back to the Future
Cecília Garlanda, Charles A. Dinarello, Alberto Mantovani|Immunity|2013|1.9k
NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control
Jan P. Böttcher, Eduardo Bonavita, Probir Chakravarty et al.|Cell|2018|1.8k
Eicosanoids and cancer
Dingzhi Wang, Raymond N. DuBois|Nature reviews. Cancer|2010|1.8k
IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis
Seth B. Coffelt, Kelly Kersten, Chris W. Doornebal et al.|Nature|2015|1.7k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
Paul M. Ridker, Jean MacFadyen, Tom Thurén et al.|The Lancet|2017|1.3k